Evidence map›Paper›PMID 24174439›Full record

ReviewILAR journal2013

Nonhuman primate models in the genomic era: a paradigm shift.

Eric J Vallender, Gregory M Miller

Abstract readReview
In one paragraph

Review in ILAR journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Evidence of potentialMicrobial genomics · 2023
    Article
  9. Review
  10. Review
  11. Article
  12. CRISPR technologies for the treatment of Duchenne muscular dystrophy.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Recent Advances in Allergy Research Using Humanized Mice.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Eric J Vallender
Gregory M Miller

Funding

New England Primate Research Center Base GrantP51OD011103 · OD · HARVARD MEDICAL SCHOOL · PI FLIER, JEFFREY S · 2012 to 2013
$24.7M
Functional genetic evolution of human brain and behaviorR01AA019688 · NIAAA · UNIVERSITY OF MISSISSIPPI MED CTR · PI VALLENDER, ERIC J. · 2010 to 2014
$1.9M
Epigenetic Regulation of Serotonin:Relevance to HIV and Methamphetamine AbuseR21DA030177 · NIDA · HARVARD MEDICAL SCHOOL · PI MILLER, GREGORY MICHAEL · 2010 to 2012
$928k
Drug Abuse-related Neurobiology and Genetic Variance Modeled in Rhesus MonkeysK02DA025697 · NIDA · HARVARD MEDICAL SCHOOL · PI MILLER, GREGORY MICHAEL · 2009 to 2013
$615k
NIAAA NIH HHS AA019688NIAAA NIH HHS R01 AA019688NIDA NIH HHS DA025697NIDA NIH HHS DA030177NIDA NIH HHS K02 DA025697NIDA NIH HHS R21 DA030177NIH HHS OD011103NIH HHS P51 OD011103
6 · The paper itself

Abstract

Because of their strong similarities to humans across physiologic, developmental, behavioral, immunologic, and genetic levels, nonhuman primates are essential models for a wide spectrum of biomedical research. But unlike other animal models, nonhuman primates possess substantial outbred genetic variation, reducing statistical power and potentially confounding interpretation of results in research studies. Although unknown genetic variation is a hindrance in studies that allocate animals randomly, taking genetic variation into account in study design affords an opportunity to transform the way that nonhuman primates are used in biomedical research. New understandings of how the function of individual genes in rhesus macaques mimics that seen in humans are greatly advancing the rhesus macaques utility as research models, but epistatic interaction, epigenetic regulatory mechanisms, and the intricacies of gene networks limit model development. We are now entering a new era of nonhuman primate research, brought on by the proliferation and rapid expansion of genomic data. Already the cost of a rhesus macaque genome is dwarfed by its purchase and husbandry costs, and complete genomic datasets will inevitably encompass each rhesus macaque used in biomedical research. Advancing this outcome is paramount. It represents an opportunity to transform the way animals are assigned and used in biomedical research and to develop new models of human disease. The genetic and genomic revolution brings with it a paradigm shift for nonhuman primates and new mandates on how nonhuman primates are used in biomedical research.

Indexed as

AnimalsGenetic VariationGenomicsHumansMacaca mulattaModels, Animalcandidate genedrug developmentmacaquepersonalized medicinepharmacogenomicsphysiogeneticspolymorphismstress

Identifiers

PMID24174439
PMCPMC3814397

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.